Schrodinger Inc
NASDAQ:SDGR

Watchlist Manager
Schrodinger Inc Logo
Schrodinger Inc
NASDAQ:SDGR
Watchlist
Price: 20.84 USD 2.32% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
Schrodinger Inc?
Write Note

Net Margin
Schrodinger Inc

-91.8%
Current
-52%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-91.8%
=
Net Income
-177.6m
/
Revenue
193.3m

Net Margin Across Competitors

Country US
Market Cap 1.5B USD
Net Margin
-92%
Country US
Market Cap 35B USD
Net Margin
24%
Country US
Market Cap 31.3B USD
Net Margin
10%
Country AU
Market Cap 23.2B AUD
Net Margin
50%
Country US
Market Cap 9B USD
Net Margin
34%
Country JP
Market Cap 967.6B JPY
Net Margin
16%
Country US
Market Cap 5.7B USD
Net Margin
4%
Country US
Market Cap 5.4B USD
Net Margin
-6%
Country SE
Market Cap 53.1B SEK
Net Margin
25%
Country US
Market Cap 2.4B EUR
Net Margin
-4%
Country CN
Market Cap 16.4B CNY
Net Margin
11%
No Stocks Found

Schrodinger Inc
Glance View

Market Cap
1.5B USD
Industry
Health Care

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 664 full-time employees. The company went IPO on 2020-02-06. The firm operates through two segments: Software and Drug Discovery. The Software segment is focused on licensing the Company’s software for molecular discovery. The Drug Discovery segment is focused on building a portfolio of preclinical and clinical drug programs, internally and through collaborations. The Company’s physics-based software platform enables discovery of molecules for drug development and materials applications. Its software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories. The Company’s pipeline includes CDC7, Wee1, MALT1, HIF-2 alpha and SOS1/KRAS. Its CDC7 is a small molecule inhibitor for treatment of solid and liquid tumors.

SDGR Intrinsic Value
14.65 USD
Overvaluation 30%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-91.8%
=
Net Income
-177.6m
/
Revenue
193.3m
What is the Net Margin of Schrodinger Inc?

Based on Schrodinger Inc's most recent financial statements, the company has Net Margin of -91.8%.